Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 22:10:1218705.
doi: 10.3389/fmed.2023.1218705. eCollection 2023.

Liquid biopsy for early detection of hepatocellular carcinoma

Affiliations
Review

Liquid biopsy for early detection of hepatocellular carcinoma

Ioana Manea et al. Front Med (Lausanne). .

Abstract

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer globally. Over 90% of HCC cases arise in the context of liver cirrhosis, and the severity of the underlying liver disease or advanced tumor stage at diagnosis significantly limits treatment options. Early diagnosis is crucial, and all guidelines stress the importance of screening protocols for HCC early detection as a public health objective. As serum biomarkers are not optimal for early diagnosis, liquid biopsy has emerged as a promising tool for diagnosis, prognostication, and patients' stratification for personalized therapy in various solid tumors, including HCC. While circulating tumor cells (CTCs) are better suited for personalized therapy and prognosis, cell-free DNA (cfDNA) and extracellular vesicle-based technologies show potential for early diagnosis, HCC screening, and surveillance protocols. Evaluating the added value of liquid biopsy genetic and epigenetic biomarkers for HCC screening is a key goal in translational research. Somatic mutations commonly found in HCC can be investigated in cfDNA and plasma exosomes as genetic biomarkers. Unique methylation patterns in cfDNA or cfDNA fragmentome features have been suggested as innovative tools for early HCC detection. Likewise, extracellular vesicle cargo biomarkers such as miRNAs and long non-coding RNAs may serve as potential biomarkers for early HCC detection. This review will explore recent findings on the utility of liquid biopsy for early HCC diagnosis. Combining liquid biopsy methods with traditional serological biomarkers could improve the overall diagnostic accuracy for early HCC detection.

Keywords: cell free DNA; early diagnosis; extracellular vesicles; hepatocellular carcinoma; liquid biopsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Liquid biopsy for early detection of hepatocellular carcinoma: current state for clinical applications, strengths, and limitations. Images have been generated using AI-powered “text to image” technology, available online: Bing Image Creator and Crayon.

Similar articles

Cited by

References

    1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M. et al. Global Cancer observatory: Cancer today. (2020). Lyon, France: International Agency for Research on Cancer Available at: https://gco.iarc.fr/today (accessed April 1, 2023).
    1. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. (2021) 73 Suppl 1:4–13. - PMC - PubMed
    1. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. . The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level. JAMA Oncol. (2017) 3:1683–91. doi: 10.1001/jamaoncol.2017.3055, PMID: - DOI - PMC - PubMed
    1. Han SS, Kelly SP, Li Y, Yang B, Nguyen M, So S, et al. . Changing landscape of liver Cancer in California: a glimpse into the future of liver Cancer in the United States. J Natl Cancer Inst. (2019) 111:550–6. - PMC - PubMed
    1. Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. (2018) 391:1301–14. doi: 10.1016/S0140-6736(18)30010-2, PMID: - DOI - PubMed